Drug
Golvatinib
Golvatinib: highest development phase Phase 1/2, developed by Eisai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Eisai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Golvatinib NCT01433991 | Phase 1/2 | Advanced Solid Tumors |
Latest
No recent events.
Follow Golvatinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.